Skip to main content
[Preprint]. 2021 Apr 12:2021.04.09.439169. [Version 2] doi: 10.1101/2021.04.09.439169

Figure 2: Inhibition of Mpro by glutathionylation can be reversed with reducing agent.

Figure 2:

Mpro was glutathionylated at pH 7.5 with 10 mM GSSG as described in the Materials and Methods and the extent of glutathionylation was determined by RP/HPLC/MALDI-TOF using a 2% acetonitrile gradient as described in materials and Methods. (A,B) Deconvoluted masses obtained by protein deconvolution of the Mpro peak (eluting between 24 and 26 min) for (A) 3 μg (5 μL injection) purified glutathionylated Mpro and (B)) 3 μg (5 μL injection) glutathionylated Mpro after a 30 min treatment with 10 mM DTT. Shown above each peak is the molecular mass (top number) and the abundance (bottom number) found by protein deconvolution. The native, monoglutathionylated (+Δ1), diglutathionylated (+Δ2), and triglutathionylated (+Δ3) Mpro, are indicated in the figures. (C) Mpro activity (1 μM final enzyme) for native and glutathionylated Mpro preparations after a 30-min incubation in the absence or presence of 10 mM DTT. Mpro activity for control in (C) and was 4.95 +/− 1.2 μM/min/mg and percent activity for the different conditions was normalized to their respective controls. The values shown are the average and standard deviation from three separate experiments (n=3) (* = p-value < 0.05, paired students t-test, ns = not significant).